CATHFLO PACKAGE INSERT PDF
PRODUCT MONOGRAPH. PR. Cathflo. ® alteplase, recombinant . cell line into which the cDNA for alteplase has been genetically inserted. Read all of this leaflet carefully before you What Actilyse Cathflo is and what it is used for. 2. Contents of the pack and other information. 1. Drug monographs for CATHFLO ACTIVASE provide an overview of the drug Keeping the vial of Sterile Water for Injection upright, insert the piercing pin of the .
|Published (Last):||8 April 2011|
|PDF File Size:||6.27 Mb|
|ePub File Size:||14.15 Mb|
|Price:||Free* [*Free Regsitration Required]|
In exploratory, multivariate analyses, age more than 77 years was among baseline characteristics cafhflo with an increased risk for intracranial hemorrhage. For neonates with cardioembolic acute ischemic stroke, anticoagulation for 3 months with either unfractionated heparin or a low molecular weight heparin is recommended.
Date range on this day between these dates. Moderate Due to the thrombocytopenic effects of vorinostat, an additive risk of bleeding may be seen in iinsert receiving concomitant thrombolytic agents.
Infants, Children, and Adolescents. Cathflo Activase has not been studied in patients known to be at risk for bleeding events that may be associated with the use of thrombolytics.
Has anyone done this? Discard any unused solution. Let me know if you have further questions! Cathflo Activase should be used with caution packaage the presence of known or suspected infection in the catheter.
Moderate An increased risk of bleeding may occur when thrombolytic agents are used following agents that cause clinically significant thrombocytopenia including antineoplastic agents. Data from published studies and case reports on alteplase use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes.
The patients described were 12, 13, and 16 years old. Such force could cause rupture of the catheter or expulsion of the clot into the circulation. Specific guidelines for dosage adjustments in renal impairment are not available; it appears that no dosage adjustments are needed. Moderate Since garlic produces clinically-significant antiplatelet effects, it should be used cautiously in patients receiving thrombolytic agents.
Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered with trazodone. This age group was excluded from acute ischemic stroke clinical trials evaluating the expanded alteplase use window.
The distribution of this agent has not been described; the initial volume of distribution approximates plasma volume. Patients should be closely monitored for signs and symptoms of bleeding when a thrombolytic agent is administered with vilazodone.
Cafhflo will take about 2 minutes. Powered by Higher Logic. Protein C Concentrate, Human: If catheter function is not restored after minutes, a second dose may be instilled.
Withdraw 2 mL 2 mg of solution from the reconstituted vial. The interaction of Cathflo Activase with other drugs has not been formally studied. Moderate Platelet aggregation may be impaired by selective serotonin reuptake inhibitors SSRIs due to platelet serotonin depletion, possibly increasing the risk of indert bleeding complication in patients receiving thrombolytic agents.
The authors concluded that fish oil supplementation in doses of 36 grams per day does not have a statistically significant effect on the INR of patients receiving chronic warfarin therapy. Central Venous Catheter Instillation Administration Alteplase packwge instilled into the occluded lumen of a central venous catheter.
Avoid intramuscular injections and nonessential handling in patients receiving systemic thrombolytic therapy with alteplase. The patient would then return to the Clinic for aspiration and flush.
Your use of third-party websites is at your apckage risk and subject to the terms and conditions of use for such sites.
Moderate Patients with thrombocytopenia are at increased risk of bleeding complications. Alteplase is administered by IV infusion. There inserg an increased risk of intracranial hemorrhage in patients with severe neurological deficit e. Long-term coadminstration is not recommended.
Dosage & Administration – Cathflo® Activase® (alteplase)
However, the use of 0. If it shows that placement is correct then we get a Md order to proceed. Submit the form below to share this with a friend or colleague. Although antifibrinolytic agents can be beneficial in the treatment of thrombolytic-induced hemorrhage, the safety of concomitant administration of these agents has not been confirmed.
Unlike streptokinase or urokinase, most of the activity of alteplase is dependent on the presence of fibrin. Major Monitor patients closely and promptly evaluate any signs or symptoms of bleeding if betrixaban and thrombolytic agents are used concomitantly.
In another controlled study, patients who did not receive concomitant IV nitroglycerin reperfused faster, more often, and had fewer reocclusions.
cxthflo Major Two separate studies have shown that concomitant administration of IV nitroglycerin can compromise the therapeutic efficacy of alteplase.
Genentech will not contact the individuals you share content vathflo. You may also report side effects to Genentech at Hypersensitivity Hypersensitivity, including urticaria, angioedema and anaphylaxis, has been reported in association with use of Cathflo Activase. Administration time varied but typically continued until complete lysis was achieved or for up to 12 hours. We have a few patients who are fibrin producers, so form the sheath.
We don’t want to “give up” too soon if practices are actually waiting this long and seeing positive results, but “chair time” may be a concern, particularly if the patient is scheduled for a long treatment that day.